Hasnain Faheem (CIK 1352620) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-05). Recent activity: Buy GOSS (280,000 shares), Buy KURA (10,000 shares), Sell KURA (10,000 shares), Buy GOSS (437,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Gossamer Bio, Inc. (GOSS) | President & CEO | Buy | 280,000 | $0 |
| 2025-12-10 | Kura Oncology, Inc. (KURA) | Director | Buy | 10,000 | $31,200 |
| 2025-12-10 | Kura Oncology, Inc. (KURA) | Director | Sell | 10,000 | $109,800 |
| 2025-10-02 | Gossamer Bio, Inc. (GOSS) | President & CEO | Buy | 437,500 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-01-05